| scholarly article | Q13442814 |
| P2093 | author name string | D C Brennan | |
| M J Koch | |||
| H Liapis | |||
| R L Kedainis | |||
| P2860 | cites work | Incidence of C4d Stain in Protocol Biopsies from Renal Allografts: Results from a Multicenter Trial | Q58378349 |
| The Banff 97 working classification of renal allograft pathology | Q59314413 | ||
| Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection | Q74644326 | ||
| Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection | Q74644344 | ||
| C4d deposition in acute rejection: an independent long-term prognostic factor | Q77374161 | ||
| Association between C4d staining in renal transplant biopsies, production of donor-specific HLA antibodies, and graft outcome | Q79820431 | ||
| C4d and C3d staining in biopsies of ABO- and HLA-incompatible renal allografts: correlation with histologic findings | Q80061434 | ||
| Complement C4d deposition in transplanted kidneys: preliminary report on long-term graft survival | Q81847915 | ||
| Chronic humoral rejection: identification of antibody-mediated chronic renal allograft rejection by C4d deposits in peritubular capillaries | Q31961631 | ||
| Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection | Q35085494 | ||
| Implications of immunohistochemical detection of C4d along peritubular capillaries in late acute renal allograft rejection | Q36017741 | ||
| Antibody-mediated renal allograft rejection: diagnosis and pathogenesis | Q36759900 | ||
| Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 | ||
| The differential diagnosis between rejection and cyclosporine toxicity. | Q40961791 | ||
| Transplant glomerulopathy, late antibody-mediated rejection and the ABCD tetrad in kidney allograft biopsies for cause | Q43580802 | ||
| Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection | Q43747982 | ||
| Detection of the complement degradation product C4d in renal allografts: diagnostic and therapeutic implications. | Q43830010 | ||
| Capillary C4d deposition in kidney allografts: a specific marker of alloantibody-dependent graft injury. | Q43931517 | ||
| Peritubular capillary changes and C4d deposits are associated with transplant glomerulopathy but not IgA nephropathy | Q44695057 | ||
| Risk factors for capillary C4d deposition in kidney allografts: evaluation of a large study cohort | Q45022068 | ||
| Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy | Q47588333 | ||
| Antibody-mediated rejection criteria - an addition to the Banff 97 classification of renal allograft rejection | Q47869308 | ||
| Plasma cell-rich acute renal allograft rejection | Q50108844 | ||
| C4d-positive chronic rejection: a frequent entity with a poor outcome. | Q51722871 | ||
| Peritubular capillaritis in renal allografts: prevalence, scoring system, reproducibility and clinicopathological correlates. | Q53033816 | ||
| Focal peritubular capillary C4d deposition in acute rejection. | Q53641782 | ||
| Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics. | Q54013696 | ||
| Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. | Q54380136 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 812-819 | |
| P577 | publication date | 2009-04-01 | |
| P1433 | published in | American Journal of Transplantation | Q4744273 |
| P1476 | title | Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival | |
| P478 | volume | 9 |
| Q91850724 | 2013 Banff Criteria for Acute Antibody-Mediated Rejection Are Superior to 2007 Banff Criteria in the Diagnosis and Assessment of Renal Allograft Outcomes |
| Q35805955 | A Randomized 2x2 Factorial Clinical Trial of Renal Transplantation: Steroid-Free Maintenance Immunosuppression with Calcineurin Inhibitor Withdrawal after Six Months Associates with Improved Renal Function and Reduced Chronic Histopathology |
| Q38228333 | A Systematic Review and Meta-Analysis of Rituximab in Antibody-mediated Renal Allograft Rejection |
| Q34796915 | A randomized 2×2 factorial trial, part 1: single-dose rabbit antithymocyte globulin induction may improve renal transplantation outcomes |
| Q38211716 | A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection |
| Q39105369 | Acute antibody-mediated rejection in kidney transplant recipients |
| Q35915453 | Antibody-mediated rejection in kidney transplantation: a review |
| Q42038591 | B-cell tolerance in transplantation: is repertoire remodeling the answer? |
| Q37058043 | Banff 2011 Meeting report: new concepts in antibody-mediated rejection |
| Q44180277 | Banff initiative for quality assurance in transplantation (BIFQUIT): reproducibility of C4d immunohistochemistry in kidney allografts |
| Q53142399 | C4d deposits in acute "cell-mediated" rejection: a marker for renal prognosis? |
| Q34927206 | C4d staining in renal allograft biopsies with early acute rejection and subsequent clinical outcome |
| Q46092609 | C4d/CD34 double-immunofluorescence staining of renal allograft biopsies for assessing peritubular capillary C4d positivity. |
| Q34841849 | Diagnosis and management of antibody-mediated rejection: current status and novel approaches |
| Q27027082 | Effector mechanisms of rejection |
| Q43037651 | Focal C4d staining in peritubular capillaries and kidney graft survival: results of a retrospective study |
| Q37375622 | Incidence and clinical significance of de novo donor specific antibodies after kidney transplantation |
| Q45172148 | Late acute humoral rejection in low-risk renal transplant recipients induced with an interleukin-2 receptor antagonist and maintained with standard therapy: preliminary communication |
| Q36529421 | Pathological diagnosis of antibody-mediated rejection in renal allograft without c4d staining, how much reliable? |
| Q53565891 | Placental C4d deposition is a feature of defective placentation: observations in cases of preeclampsia and miscarriage. |
| Q37925104 | Proteasome inhibitor therapy for antibody-mediated rejection |
| Q52845695 | Renal Association Clinical Practice Guideline on post-operative care of the kidney transplant recipient. |
| Q42343473 | Renal association clinical practice guideline in post-operative care in the kidney transplant recipient |
| Q33396969 | Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. |
| Q57474736 | Rituximab, plasma exchange and immunoglobulins: an ineffective treatment for chronic active antibody-mediated rejection |
| Q88375262 | Soluble CD30, Acute Rejection, and Graft Survival: Pre- and 6-Month Post-Transplant Determinations-When Is the Best Time to Measure? |
| Q84647484 | The impact of C4d staining as a humoral injury marker |
| Q38003049 | The impact of donor-specific anti-HLA antibodies on late kidney allograft failure |
| Q35865046 | The impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study |
Search more.